Total planned funding: $116,882,040
Allocations
Countries/Regions
Ukraine | $116,882,040 |
Organizational Types
Private Contractor | $32,764,481 |
Unknown | $25,143,032 |
NGO | $17,728,854 |
Multi-lateral Agency | $15,001,607 |
Own Agency | $12,859,972 |
University | $5,460,000 |
Other USG Agency | $5,224,094 |
Implementing Agency | $2,700,000 |
Program Areas
Governance and Systems | $51,395,047 |
Treatment | $24,505,798 |
Prevention | $12,018,462 |
Testing | $11,508,250 |
Care | $9,272,692 |
Management and Operations | $8,181,791 |
Budget Codes
OHSS: Health Systems Strengthening | $24,214,878 |
HVSI: Strategic Information | $16,690,940 |
HTXS: Treatment: Adult Treatment | $13,100,508 |
HVCT: Testing: HIV Testing and Counseling | $11,508,250 |
HTXD: Treatment: ARV Drugs | $11,405,290 |
HLAB: Laboratory Infrastructure | $10,489,229 |
HVMS: Management and Operations | $8,181,791 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $6,085,928 |
HVTB: Care: TB/HIV | $5,323,242 |
HVOP: Sexual Prevention: Other Sexual Prevention | $3,046,055 |
HMBL: Biomedical Prevention: Blood Safety | $2,460,722 |
HBHC: Care: Adult Care and Support | $2,145,590 |
HKID: Care: Orphans and Vulnerable Children | $1,803,860 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $293,357 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $132,400 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Not Available:
$25,143,032
Countries/Regions
Chemonics International:
$17,739,470
Countries/Regions
Deloitte Consulting Limited:
$13,725,011
Countries/Regions
USG Aggregated Agencies:
$12,044,972
Countries/Regions